NCT06990659 2026-03-11
CHOC
University Hospital, Angers
Phase NA Recruiting
Clinical Trials
65 trialsNCT07310836 2025-12-30
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
Ningbo Medical Center Lihuili Hospital
Not yet recruiting
NCT07306481 2025-12-29
The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer
Fujian Cancer Hospital
Phase NA Not yet recruiting
NCT07291141 2025-12-19
DETECT-HCC
Linkoeping University
Recruiting
NCT07293468 2025-12-19
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
NCT03071458 2025-12-10
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
Completed
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT07170345 2025-09-12
HCC-MVI-CAD
Chinese Academy of Sciences
Recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT07128251 2025-08-17
A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT07119957 2025-08-13
ProspEXPO
University Hospital, Angers
Phase NA Not yet recruiting
NCT06971848 2025-07-11
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT03093688 2025-07-02
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Recruiting
NCT05623150 2025-03-13
CHALNA2
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT06594744 2025-02-13
P-HCC-CVL
Taipei Veterans General Hospital, Taiwan
Phase 4 Recruiting
NCT06685354 2024-11-12
Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06498622 2024-07-12
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
Anhui Provincial Hospital
Phase 2 Recruiting
NCT06478927 2024-06-27
Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib
Henan Cancer Hospital
Phase NA Recruiting
NCT06384950 2024-04-25
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Phase NA Recruiting
NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
NCT06096896 2023-10-24
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
Shandong Provincial Hospital
Active not recruiting
NCT05047510 2023-08-30
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
Chinese Academy of Sciences
Phase NA Recruiting
NCT05502198 2023-08-24
ACCESS-ESLD
Linkoeping University
Recruiting
NCT05897138 2023-06-13
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05887505 2023-06-06
Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy
Taoyuan General Hospital
Phase NA Not yet recruiting
NCT05407519 2023-03-22
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
Anhui Provincial Hospital
Phase 2 Recruiting
NCT05738980 2023-02-22
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
Beijing Hospital
Phase NA Recruiting
NCT05370001 2023-02-13
Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation
Region Stockholm
Phase NA Completed
NCT05545124 2022-09-19
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence
Henan Cancer Hospital
Phase 2 Unknown
NCT05391867 2022-05-26
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma
Sir Salimullah Medical College Mitford Hospital
Phase NA Unknown
NCT02794337 2022-04-27
TACE-SBRT
Tata Memorial Hospital
Phase 2/3 Unknown
NCT05024539 2022-04-05
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
Henan Cancer Hospital
Unknown
NCT04721470 2021-01-22
Combined Therapy for Hepatocellular Carcinoma >3-<5 cm
Zagazig University
Phase NA Completed
NCT04687280 2020-12-29
CHIC MultiA
University Hospital, Angers
Completed
NCT04652947 2020-12-03
MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison
University Hospital, Angers
Completed
NCT04270461 2020-10-22
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Jiujiang University Affiliated Hospital
Phase 1 Withdrawn
NCT04568330 2020-09-29
Prevention of Hand-foot Skin Reaction
Taipei Veterans General Hospital, Taiwan
Phase NA Completed
NCT04546802 2020-09-14
HATCHeT
Bayside Health
Phase 3 Withdrawn
NCT02395523 2020-07-07
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT01451658 2019-09-04
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01970748 2019-08-30
P-HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01643824 2018-08-23
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT03292991 2017-09-26
REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)
Taipei Veterans General Hospital, Taiwan
Unknown
NCT03273608 2017-09-06
Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients
Taipei Veterans General Hospital, Taiwan
Unknown
NCT02959359 2017-08-07
DAA in the Risk of Recurrence After Curative Treatment of HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Withdrawn
NCT03138239 2017-05-03
The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02771405 2016-05-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Unknown
NCT02757846 2016-05-02
Radiomics of Hepatocellular Carcinoma
Chinese Academy of Sciences
Unknown
NCT02534961 2015-08-28
Prophylactic Antibiotics Before RFA for HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT02327819 2014-12-30
The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
Tel-Aviv Sourasky Medical Center
Phase NA Unknown